Most Recent
A contradictor in two pelvic mesh class actions against Johnson & Johnson has opposed Shine Lawyers recovering $100 million in costs from a $300 million settlement, which a judge has preliminarily found is not fair and reasonable to group members.
Israeli drug company Neurim Pharmaceuticals has lost a bid to patent a mini version of its melatonin tablet Circadin for children, after a successful challenge by Australian drug maker Generic Partners.
Trial in the battle of the buns has begun, with McDonald's laying out a case for why its rival's Big Jack burger infringes its trade mark, and Hungry Jack's firing back that consumers could not confuse its flame-grilled meal with the iconic Big Mac.
A litigation funder has abandoned its case seeking to prevent counsel retained by the lead applicant in the settled Montara oil spill class action from providing independent legal advice.
Former defence minister Linda Reynolds is facing a civil suit by former staffer Brittany Higgins in relation to her alleged rape inside Reynold’s Parliament House office in 2019.
Mining company Quantum Graphite has filed proceedings against accounting firm Grant Thornton over a 2020 report that caused the Australian Stock Exchange to suspend trading in the mining company’s securities for 14 months.
The Albanese government has succeeded in advancing labor reforms that it says will strengthen access to wage bargaining, encourage job security and gender equity, and bolster the role of the Fair Work Commission.
Developer JD Group has scored a partial win in its challenge to a damages award to a Melbourne couple over a “deliberately misleading” rendering of a $9.6 million apartment, with a judge saying the case showed the “inherent risk” in buying apartments off-the-plan.
US lingerie and beauty giant Victoria’s Secret has won undertakings from Chemist Warehouse to stop selling allegedly fake fragrance products until a trade mark suit against the pharmacy giant is decided.
Vanguard Investments has coughed up almost $40,000 for allegedly misleading investors about funds that purportedly did not invest in companies that sell or manufacture tobacco.